Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05333055 · ClinicalTrials.gov registry record
Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema
A clinical trial, sponsored by Greater Houston Retina Research.
- Terminated
- Registry status
- 107
- Enrollment target
NCT05333055 is a clinical trial that was terminated before completion, run by Greater Houston Retina Research. The registered enrollment target is 107 participants.
The verdict
NCT05333055 was terminated before completion, sponsored by Greater Houston Retina Research.
- TERMINATED
- Registry status
- 107 participants
- Enrollment target
Study Summary
The DRAGONS study is a non-interventional, prospective study that will 1. characterize disease state biomarker (including cytokines, KKS metabolites, and cell adhesion molecules) levels from aqueous humor of subjects with various stages of diabetic retinopathy (DR) and diabetic macular edema (DME) as well as other retinal pathologies, and 2. correlate a broad array of aqueous humor disease state biomarkers with DR severity, DME anti-vascular endothelial growth factor (VEGF) responsiveness, and other retinal pathologies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2024-05-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05333055
The ClinicalTrials.gov registry entry for NCT05333055 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Greater Houston Retina Research, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05333055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05333055 about?
NCT05333055 is a clinical study titled "Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema". The DRAGONS study is a non-interventional, prospective study that will 1. characterize disease state biomarker (including cytokines, KKS metabolites, and cell adhesion molecules) levels from aqueous humor of subjects with various stages of diabetic retinopathy (DR) and diabetic macular edema (DME) ...
What is the current status of trial NCT05333055?
This trial is currently terminated. The enrollment target is 107 participants. The study started on 2022-02-10. Estimated completion is 2024-05-15.
Who is sponsoring clinical trial NCT05333055?
This trial is sponsored by Greater Houston Retina Research, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.